Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
Cell Host & Microbe|May 21, 2013
Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infectionStefan Jordan, Zsolt Ruzsics, Maja Mitrović, et al.Journal of Virology|February 15, 2005
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoproteinMilena Hasan, Astrid Krmpotic, Zsolt Ruzsics, et al.Plos Pathogens|August 29, 2007
Natural killer cells promote early CD8 T cell responses against cytomegalovirusScott H Robbins, Gilles Bessou, Amélie Cornillon, et al.Journal of Neuroinflammation|March 29, 2025
Neuron-restricted cytomegalovirus latency in the central nervous system regulated by CD4<sup>+</sup> T-cells and IFN-γFran Krstanović, Andrea Mihalić, Ahmad Seyar Rashidi, et al.RNA (New York, N.Y.)|July 29, 2008
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decayLars Dölken, Zsolt Ruzsics, Bernd Rädle, et al.Frontiers in Immunology|August 14, 2024
Inhibition of B cell receptor signaling induced by the human adenovirus species D E3/49K proteinAndreas Hildenbrand, Precious Cramer, Milena Bertolotti, et al.The Journal of Experimental Medicine|July 13, 2006
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60Tihana Lenac, Matthias Budt, Jurica Arapovic, et al.Plos Pathogens|November 15, 2008
Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivoGyörgy Fejer, Lisa Drechsel, Jan Liese, et al.Molecular Therapy. Oncology|April 10, 2024
TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1Christina Funk, Nadja Uhlig, Zsolt Ruzsics, et al.Molecular Therapy Oncolytics|January 24, 2022
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma culturesAleksei A Stepanenko, Anastasiia O Sosnovtseva, Marat P Valikhov, et al.Pageof 10